No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PLTRPalantir Technologies Inc. | 404.49B | 177.07 | 931.95 | 28.79% | 28.11% | 16.38% | 0.28% | 0.05 |
| CCCCCC Intelligent Solutions Holdings Inc. | 5.17B | 8.07 | 198.28 | 9.05% | -0.28% | -0.13% | 4.46% | 0.42 |
| ODDOddity Tech Ltd. | 1.62B | 35.34 | 21.29 | 27.2% | 14.11% | 28.94% | 8% | 0.08 |
| MLGOMicroAlgo Inc. | 66.31M | 6.06 | 11.02 | -9.22% | 11.11% | 2.12% | 6.14% | 0.16 |
| STEMStem, Inc. | 165.29M | 19.70 | -0.19 | -68.67% | 62.2% | -59.21% | ||
| WRDWeRide Inc. | 2.83B | 8.73 | -0.95 | -10.13% | -6.97% | -125.4% | 0.02 | |
| AISPAirship AI Holdings, Inc. | 123.03M | 3.60 | -1.89 | 87.4% | -364.1% | |||
| ARBEArbe Robotics Ltd. | 129.54M | 1.19 | -1.95 | -47.76% | -70.78% | -96.13% | 1.45 |
| Mar 2014 | Mar 2015 | Dec 2017 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 17.11M | 26.53M | 56.32M | 433.46M | 457.11M | 443.46M | 474.04M | 312.06M | 313.4M | 350.63M |
| Revenue Growth % | 0.12% | 0.55% | 1.12% | 6.7% | 0.05% | -0.03% | 0.07% | -0.34% | 0% | 0.12% |
| Cost of Goods Sold | 12.61M | 3.13M | 18.87M | 176.77M | 164M | 132.67M | 132.4M | 119.94M | 98M | 103.71M |
| COGS % of Revenue | 0.74% | 0.12% | 0.34% | 0.41% | 0.36% | 0.3% | 0.28% | 0.38% | 0.31% | 0.3% |
| Gross Profit | 4.5M | 23.4M | 37.44M | 256.69M | 293.1M | 310.79M | 341.64M | 192.13M | 215.4M | 246.92M |
| Gross Margin % | 0.26% | 0.88% | 0.66% | 0.59% | 0.64% | 0.7% | 0.72% | 0.62% | 0.69% | 0.7% |
| Gross Profit Growth % | 0.04% | 4.2% | 0.6% | 5.86% | 0.14% | 0.06% | 0.1% | -0.44% | 0.12% | 0.15% |
| Operating Expenses | 11.94M | 31.05M | 38.33M | 238M | 265.79M | 292.51M | 330.68M | 295.45M | 233.46M | 252.05M |
| OpEx % of Revenue | 0.7% | 1.17% | 0.68% | 0.55% | 0.58% | 0.66% | 0.7% | 0.95% | 0.74% | 0.72% |
| Selling, General & Admin | 9.84M | 7.96M | 8.29M | 137.34M | 153.9M | 162.59M | 185.87M | 154.35M | 125.78M | 143.52M |
| SG&A % of Revenue | 0.58% | 0.3% | 0.15% | 0.32% | 0.34% | 0.37% | 0.39% | 0.49% | 0.4% | 0.41% |
| Research & Development | 2.1M | 2.85M | 4.74M | 100.01M | 111.3M | 128.71M | 143.36M | 140.32M | 107.28M | 108.27M |
| R&D % of Revenue | 0.12% | 0.11% | 0.08% | 0.23% | 0.24% | 0.29% | 0.3% | 0.45% | 0.34% | 0.31% |
| Other Operating Expenses | 0 | 20.24M | 25.3M | 651K | 593K | 1.22M | 1.46M | 779K | 391K | 258K |
| Operating Income | -7.44M | -7.65M | 1.5B | 18.69M | 27.31M | 18.28M | 10.96M | -103.32M | -18.05M | -5.13M |
| Operating Margin % | -0.44% | -0.29% | 26.64% | 0.04% | 0.06% | 0.04% | 0.02% | -0.33% | -0.06% | -0.01% |
| Operating Income Growth % | 0.12% | -0.03% | 197.19% | -0.99% | 0.46% | -0.33% | -0.4% | -10.43% | 0.83% | 0.72% |
| EBITDA | -6.75M | -7.37M | 1.5B | 39.71M | 44.64M | 40.8M | 32.24M | -85.27M | -4.24M | 8.53M |
| EBITDA Margin % | -0.39% | -0.28% | 26.7% | 0.09% | 0.1% | 0.09% | 0.07% | -0.27% | -0.01% | 0.02% |
| EBITDA Growth % | 0.12% | -0.09% | 205.05% | -0.97% | 0.12% | -0.09% | -0.21% | -3.65% | 0.95% | 3.01% |
| D&A (Non-Cash Add-back) | 695K | 278.95K | 3.17M | 21.02M | 17.32M | 22.52M | 21.28M | 18.05M | 13.82M | 13.65M |
| EBIT | -7.51M | -7.64M | 1.5B | 20.44M | 30.42M | 24.91M | 8.46M | -95.4M | -13.24M | -4.27M |
| Net Interest Income | -188K | 511 | 245.65M | 2.67M | 3.03M | 1.16M | -19K | -823K | 1.88M | 2.37M |
| Interest Income | 4K | 1K | 245.68M | 3.17M | 3.51M | 1.35M | 177K | 774K | 1.9M | 2.47M |
| Interest Expense | 192K | 489 | 29.03K | 499K | 481K | 185K | 196K | 1.6M | 16K | 100K |
| Other Income/Expense | -258K | 3.69K | -1.5B | 1.25M | 2.62M | 6.45M | -2.7M | 6.33M | 4.79M | 756K |
| Pretax Income | -7.7M | -7.64M | -617K | 19.94M | 29.94M | 24.72M | 8.26M | -97M | -13.26M | -4.37M |
| Pretax Margin % | -0.45% | -0.29% | -0.01% | 0.05% | 0.07% | 0.06% | 0.02% | -0.31% | -0.04% | -0.01% |
| Income Tax | 12K | 65.51K | 137.12K | 7.62M | 2.57M | 4.41M | 18.52M | 12.96M | -1.61M | 2.86M |
| Effective Tax Rate % | 1% | 1.01% | 1.43% | 0.44% | 0.67% | 0.57% | -1.8% | 1.18% | 1.17% | 2.76% |
| Net Income | -7.71M | -7.71M | -883K | 8.73M | 20.19M | 14.2M | -14.89M | -114.13M | -15.57M | -12.05M |
| Net Margin % | -0.45% | -0.29% | -0.02% | 0.02% | 0.04% | 0.03% | -0.03% | -0.37% | -0.05% | -0.03% |
| Net Income Growth % | 0.27% | 0% | 0.89% | 10.88% | 1.31% | -0.3% | -2.05% | -6.67% | 0.86% | 0.23% |
| Net Income (Continuing) | -7.71M | -7.71M | -883K | 12.32M | 27.37M | 20.31M | -10.26M | -109.95M | -11.64M | -7.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 7.71M | 10.63M | 12.87M | 13.95M | 15.64M | 16.86M | 18.91M |
| EPS (Diluted) | -0.17 | -0.15 | -0.01 | 0.13 | 0.31 | 0.22 | -0.22 | -1.68 | -0.22 | -0.17 |
| EPS Growth % | 0.26% | 0.12% | 0.9% | 9.84% | 1.38% | -0.29% | -2% | -6.64% | 0.87% | 0.23% |
| EPS (Basic) | -0.30 | -0.30 | -0.01 | 0.13 | 0.31 | 0.22 | -0.22 | -1.68 | -0.22 | -0.17 |
| Diluted Shares Outstanding | 46.16M | 52.98M | 59.98M | 65.77M | 65.4M | 65.77M | 66.57M | 67.92M | 70.08M | 71.8M |
| Basic Shares Outstanding | 25.51M | 25.51M | 59.98M | 65.4M | 65.4M | 65.77M | 66.57M | 67.92M | 70.08M | 71.8M |
| Dividend Payout Ratio | - | - | - | - | - | 0.29% | - | - | - | - |
| Mar 2014 | Mar 2015 | Dec 2017 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 9.7M | 0 | 43.68M | 569.54M | 512.2M | 350.24M | 420.06M | 251.72M | 264.98M | 286.15M |
| Cash & Short-Term Investments | 1.24M | 0 | 27.16M | 271.25M | 207.69M | 83.28M | 163.02M | 52.09M | 74.48M | 112.72M |
| Cash Only | 1.24M | 0 | 20.91M | 240.19M | 201.09M | 78.57M | 152.59M | 34.58M | 74.48M | 112.72M |
| Short-Term Investments | 0 | 0 | 6.25M | 31.06M | 6.6M | 4.71M | 10.43M | 17.51M | 0 | 0 |
| Accounts Receivable | 3.82M | 0 | 8.28M | 203.81M | 211.34M | 196.7M | 207.11M | 137.71M | 122.12M | 122.8M |
| Days Sales Outstanding | 81.46 | - | 53.64 | 171.62 | 168.76 | 161.9 | 159.47 | 161.07 | 142.22 | 127.83 |
| Inventory | 4.19M | 0 | 7.18M | 16.75M | 14.89M | 14.54M | 14.37M | 25.26M | 24.58M | 18.99M |
| Days Inventory Outstanding | 121.4 | - | 138.8 | 34.59 | 33.15 | 40.01 | 39.6 | 76.88 | 91.56 | 66.83 |
| Other Current Assets | 455K | 0 | 1.08M | 54.17M | 54.36M | 33.68M | 12.91M | 7.59M | 17.1M | 4.8M |
| Total Non-Current Assets | 1.13M | 0 | 31.06M | 235.8M | 292.91M | 278.58M | 244.54M | 191.35M | 207.1M | 211.67M |
| Property, Plant & Equipment | 1.06M | 0 | 2.43M | 34.76M | 75.73M | 69.72M | 55.87M | 43.43M | 58.22M | 63.53M |
| Fixed Asset Turnover | 16.11x | - | 23.20x | 12.47x | 6.04x | 6.36x | 8.48x | 7.18x | 5.38x | 5.52x |
| Goodwill | 0 | 0 | 19.15M | 147.15M | 158.14M | 158.18M | 158.23M | 126.49M | 126.56M | 126.15M |
| Intangible Assets | 0 | 0 | 7.36M | 12.52M | 19.55M | 5.3M | 3.16M | 650K | 8.63M | 8.11M |
| Long-Term Investments | 0 | 0 | 1.87M | 3.94M | 1.9M | 0 | 5.16M | 7.05M | 7.19M | 6.41M |
| Other Non-Current Assets | 67K | 0 | 0 | 29.92M | 35.58M | 42.08M | 20.57M | 12.91M | 3.58M | 4.37M |
| Total Assets | 10.83M | 0 | 74.74M | 805.35M | 805.11M | 628.82M | 664.61M | 443.08M | 472.08M | 497.82M |
| Asset Turnover | 1.58x | - | 0.75x | 0.54x | 0.57x | 0.71x | 0.71x | 0.70x | 0.66x | 0.70x |
| Asset Growth % | -0.05% | -1% | - | 9.77% | -0% | -0.22% | 0.06% | -0.33% | 0.07% | 0.05% |
| Total Current Liabilities | 2.84M | 10.25B | 9.38M | 268.41M | 280.06M | 299.03M | 319.6M | 193.86M | 190.47M | 219.36M |
| Accounts Payable | 1.22M | 3.97B | 45.72M | 45.72M | 43.39M | 41.55M | 36.66M | 20.68M | 20.86M | 25.22M |
| Days Payables Outstanding | 35.23 | 463.46K | 884.24 | 94.4 | 96.56 | 114.32 | 101.08 | 62.93 | 77.7 | 88.75 |
| Short-Term Debt | 0 | 0 | 0 | 13.03M | 7.03M | 38.77M | 100M | 6.6M | 0 | 0 |
| Deferred Revenue (Current) | 210K | 0 | 774.63K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 1.41M | 6.29B | 5.62M | 52.7M | 62.67M | 65.35M | 67.94M | 23.71M | 48.91M | 55.29M |
| Current Ratio | 3.42x | - | 4.66x | 2.12x | 1.83x | 1.17x | 1.31x | 1.30x | 1.39x | 1.30x |
| Quick Ratio | 1.94x | - | 3.89x | 2.06x | 1.78x | 1.12x | 1.27x | 1.17x | 1.26x | 1.22x |
| Cash Conversion Cycle | 167.63 | - | -691.8 | 111.81 | 105.34 | 87.59 | 97.99 | 175.02 | 156.08 | 105.92 |
| Total Non-Current Liabilities | 22.51M | 23.75B | 1.33M | 61.62M | 69.88M | 59.42M | 45.92M | 39.45M | 66.88M | 61.36M |
| Long-Term Debt | 22.41M | 22.53B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 192K | 26.96M | 24.14M | 17.18M | 10.37M | 27.95M | 30.53M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 28.5M | 11.66M | 4.05M | 3.45M | 3.03M | 1.96M | 5.78M |
| Other Non-Current Liabilities | 0 | 1.22B | 1.33M | 40.45M | 14.89M | 9.2M | 10.77M | 11.67M | 7.61M | 2.18M |
| Total Liabilities | 25.35M | 34B | 10.71M | 330.03M | 349.94M | 358.45M | 365.52M | 233.3M | 257.35M | 280.72M |
| Total Debt | 22.44M | 22.53B | 214K | 13.23M | 40.04M | 69.99M | 124.59M | 16.97M | 33.36M | 35.53M |
| Net Debt | 21.2M | 22.53B | -20.7M | -226.97M | -161.05M | -8.58M | -28M | -17.61M | -41.11M | -77.19M |
| Debt / Equity | - | 0.99x | 0.00x | 0.03x | 0.09x | 0.26x | 0.42x | 0.08x | 0.16x | 0.16x |
| Debt / EBITDA | - | - | 0.00x | 0.33x | 0.90x | 1.72x | 3.86x | - | - | 4.17x |
| Net Debt / EBITDA | - | - | -0.01x | -5.72x | -3.61x | -0.21x | -0.87x | - | - | -9.05x |
| Interest Coverage | -38.77x | -15638.04x | 51672.83x | 37.45x | 56.78x | 98.79x | 55.92x | -64.70x | -1128.38x | -51.26x |
| Total Equity | -14.52M | 22.75B | 64.04M | 475.32M | 455.17M | 270.37M | 299.09M | 209.77M | 214.73M | 217.1M |
| Equity Growth % | -0.69% | 1568.2% | -1% | 6.42% | -0.04% | -0.41% | 0.11% | -0.3% | 0.02% | 0.01% |
| Book Value per Share | -0.31 | 429.40 | 1.07 | 7.23 | 6.96 | 4.11 | 4.49 | 3.09 | 3.06 | 3.02 |
| Total Shareholders' Equity | -14.52M | 22.75B | 64.04M | 467.61M | 444.54M | 257.5M | 285.14M | 194.13M | 197.88M | 198.19M |
| Common Stock | 476K | 256.76M | 609.06K | 481.07M | 458.47M | 273.01M | 0 | 0 | 0 | 0 |
| Retained Earnings | -117.54M | -51.88B | -82M | 0 | 0 | 0 | -14.89M | -129.02M | -144.59M | -156.64M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.28M |
| Accumulated OCI | -4.3M | -1.16B | -4.63M | -13.46M | -13.92M | -15.51M | -16.68M | -15.31M | -12.63M | -14.02M |
| Minority Interest | 0 | 0 | 0 | 7.71M | 10.63M | 12.87M | 13.95M | 15.64M | 16.86M | 18.91M |
| Mar 2014 | Mar 2015 | Dec 2017 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -5.92M | -4.36M | 2.31M | 53.73M | 67.19M | 71.31M | 2.63M | -36.99M | 34.56M | 46.78M |
| Operating CF Margin % | -0.35% | -0.16% | 0.04% | 0.12% | 0.15% | 0.16% | 0.01% | -0.12% | 0.11% | 0.13% |
| Operating CF Growth % | 0.39% | 0.26% | 1.53% | 22.3% | 0.25% | 0.06% | -0.96% | -15.06% | 1.93% | 0.35% |
| Net Income | -7.71M | -7.71M | -882.75K | 12.32M | 27.37M | 20.31M | -10.26M | -109.95M | -15.57M | -7.23M |
| Depreciation & Amortization | 695K | 278.95K | 3.17M | 21.02M | 17.32M | 22.52M | 21.28M | 18.05M | 13.82M | 13.65M |
| Stock-Based Compensation | 694K | 0 | 1.45B | 25.54M | 31.03M | 27.42M | 32.87M | 25.25M | 12.19M | 19.03M |
| Deferred Taxes | 0 | -83.4K | -80.05K | 9M | 5.6M | -2.19M | 5.86M | 45K | -3.2M | -1.36M |
| Other Non-Cash Items | 66K | 215.48K | 185.01K | -2.58M | -2.69M | -4.68M | 931K | -1.89M | 1.29M | 1.27M |
| Working Capital Changes | 344K | 1.54M | -1.53M | -11.56M | -11.46M | 7.94M | -48.05M | 31.52M | 26.03M | 21.42M |
| Change in Receivables | -215K | -337.84K | -661.77K | -44.14M | -24.14M | 1.5M | -5.72M | 59.19M | 5.1M | 3.85M |
| Change in Inventory | 692K | 140.61K | 276.09K | -3.62M | -392K | -1.14M | -363K | -13.1M | -960K | 4.57M |
| Change in Payables | -83K | 231.66K | -90.32K | -7.75M | 1.31M | 8.67M | 4.88M | -37.88M | 4.33M | 14.29M |
| Cash from Investing | -90K | -50K | 9.54B | -68.34M | -29.54M | 16.42M | -17.85M | 20.13M | 9.36M | -5.69M |
| Capital Expenditures | -53K | -420.73K | -856.88K | -12.61M | -21.33M | -19.33M | -17.79M | -11.68M | -7.04M | -10.59M |
| CapEx % of Revenue | 0% | 0.02% | 0.02% | 0.03% | 0.05% | 0.04% | 0.04% | 0.04% | 0.02% | 0.03% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -37K | -3.08M | 9.71B | -22.43M | -13.95M | 38.29M | 6.07M | 358K | -4.82M | -164K |
| Cash from Financing | 7.85M | 6.41M | -276.6M | 6.06M | -85.97M | -205.62M | 58.74M | -102.93M | -2.45M | -7.95M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | -4.18M | -35M | -2.93M | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 6.41M | 6.41M | -276.6M | 32K | -79.97M | -194.42M | -6.26M | 0 | -2.45M | -2.58M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -5.97M | -4.79M | 1.45M | 41.13M | 45.86M | 51.98M | -15.16M | -48.67M | 25.49M | 33.59M |
| FCF Margin % | -0.35% | -0.18% | 0.03% | 0.09% | 0.1% | 0.12% | -0.03% | -0.16% | 0.08% | 0.1% |
| FCF Growth % | 0.39% | 0.2% | 1.3% | 27.37% | 0.12% | 0.13% | -1.29% | -2.21% | 1.52% | 0.32% |
| FCF per Share | -0.13 | -0.09 | 0.02 | 0.63 | 0.70 | 0.79 | -0.23 | -0.72 | 0.36 | 0.47 |
| FCF Conversion (FCF/Net Income) | 0.77x | 0.57x | -2.61x | 6.16x | 3.33x | 5.02x | -0.18x | 0.32x | -2.22x | -3.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 38K | 470K | 1.98M | 663K | 504K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 1.26M | 8.23M | 11.28M | 6.77M | 7.15M |
| Metric | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -0.07% | -0.01% | 3.24% | 4.34% | 3.92% | -5.23% | -44.86% | -7.34% | -5.58% |
| Return on Invested Capital (ROIC) | -77.56% | -0.03% | 4.97% | 9.61% | 7.55% | 4.93% | 3.09% | -33.46% | -7.4% | -2.45% |
| Gross Margin | 26.29% | 88.22% | 66.49% | 59.22% | 64.12% | 70.08% | 72.07% | 61.57% | 68.73% | 70.42% |
| Net Margin | -45.09% | -29.06% | -1.57% | 2.01% | 4.42% | 3.2% | -3.14% | -36.57% | -4.97% | -3.44% |
| Debt / Equity | - | 0.99x | 0.00x | 0.03x | 0.09x | 0.26x | 0.42x | 0.08x | 0.16x | 0.16x |
| Interest Coverage | -38.77x | -15638.04x | 51672.83x | 37.45x | 56.78x | 98.79x | 55.92x | -64.70x | -1128.38x | -51.26x |
| FCF Conversion | 0.77x | 0.57x | -2.61x | 6.16x | 3.33x | 5.02x | -0.18x | 0.32x | -2.22x | -3.88x |
| Revenue Growth | 11.91% | 55.05% | 112.3% | 669.69% | 5.46% | -2.99% | 6.9% | -34.17% | 0.43% | 11.88% |
| 2013 | 2014 | 2015 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Technology Service | - | - | - | - | 190.01M | 201.56M | 175.69M | 165.03M | 180.87M |
| Technology Service Growth | - | - | - | - | - | 6.08% | -12.84% | -6.07% | 9.60% |
| Product | - | - | - | - | 187.24M | 209.99M | 98.29M | 113.54M | 125.81M |
| Product Growth | - | - | - | - | - | 12.15% | -53.19% | 15.52% | 10.81% |
| Professional Services And Other | - | - | - | - | 66.21M | 62.49M | 38.08M | 34.84M | 43.95M |
| Professional Services And Other Growth | - | - | - | - | - | -5.62% | -39.06% | -8.53% | 26.15% |
| Urology | - | - | - | 49.31M | - | - | - | - | - |
| Urology Growth | - | - | - | - | - | - | - | - | - |
| Industrial | 4.6M | - | - | 3.73M | - | - | - | - | - |
| Industrial Growth | - | - | - | - | - | - | - | - | - |
| Airway Management | - | - | - | 3.28M | - | - | - | - | - |
| Airway Management Growth | - | - | - | - | - | - | - | - | - |
| Medical | 14.68M | - | - | - | - | - | - | - | - |
| Medical Growth | - | - | - | - | - | - | - | - | - |
| 2013 | 2014 | 2015 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| ISRAEL | - | - | - | - | 274.11M | 328.37M | 201.61M | 215.31M | 242.93M |
| ISRAEL Growth | - | - | - | - | - | 19.79% | -38.60% | 6.80% | 12.83% |
| GERMANY | - | - | - | - | 86.83M | 63.26M | 44.49M | 53.48M | 53.97M |
| GERMANY Growth | - | - | - | - | - | -27.15% | -29.68% | 20.22% | 0.91% |
| Other EMEA Region | - | - | - | - | 18.73M | 14.13M | 13.21M | 14.95M | 19M |
| Other EMEA Region Growth | - | - | - | - | - | -24.56% | -6.51% | 13.19% | 27.10% |
| UNITED STATES | - | 11.44M | - | - | 44.75M | 37.73M | 35.14M | 10.03M | 14.24M |
| UNITED STATES Growth | - | - | - | - | - | -15.69% | -6.86% | -71.46% | 41.96% |
| Asia Pacific | - | - | - | - | 11.9M | 12.69M | 7.63M | 12.49M | 13.82M |
| Asia Pacific Growth | - | - | - | - | - | 6.61% | -39.86% | 63.58% | 10.70% |
| Other Americas Region | - | - | - | - | 7.13M | 17.87M | 9.99M | 7.15M | 6.67M |
| Other Americas Region Growth | - | - | - | - | - | 150.48% | -44.11% | -28.44% | -6.63% |
| United States | - | - | 19.97M | 40.89M | - | - | - | - | - |
| United States Growth | - | - | - | 104.75% | - | - | - | - | - |
| All Other Foreign Countries | - | - | 4.05M | 15.43M | - | - | - | - | - |
| All Other Foreign Countries Growth | - | - | - | 280.94% | - | - | - | - | - |
| Europe | - | 4.64M | - | - | - | - | - | - | - |
| Europe Growth | - | - | - | - | - | - | - | - | - |
| Asia And Australia | - | 349K | - | - | - | - | - | - | - |
| Asia And Australia Growth | - | - | - | - | - | - | - | - | - |
| CANADA | - | 274K | - | - | - | - | - | - | - |
| CANADA Growth | - | - | - | - | - | - | - | - | - |
| Middle East And Africa | - | 254K | - | - | - | - | - | - | - |
| Middle East And Africa Growth | - | - | - | - | - | - | - | - | - |
| Latin America | - | 154K | - | - | - | - | - | - | - |
| Latin America Growth | - | - | - | - | - | - | - | - | - |
Cognyte Software Ltd. (CGNT) reported $376.6M in revenue for fiscal year 2025. This represents a 3383% increase from $10.8M in 2010.
Cognyte Software Ltd. (CGNT) grew revenue by 11.9% over the past year. This is steady growth.
Cognyte Software Ltd. (CGNT) reported a net loss of $4.5M for fiscal year 2025.
Cognyte Software Ltd. (CGNT) has a return on equity (ROE) of -5.6%. Negative ROE indicates the company is unprofitable.
Cognyte Software Ltd. (CGNT) generated $11.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.